Influence of apurinic acid on programmed synthesis in different in vitro systems.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001667:Binding, Competitive; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002474:Cell-Free System; D004254:DNA Nucleotidyltransferases / Q000037:antagonists & inhibitors*; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors*; D003851:Deoxyribonucleases / Q000037:antagonists & inhibitors; D003854:Deoxyribonucleotides / Q000494:pharmacology; D004926:Escherichia coli / Q000201:enzymology; D007942:Leukemia, Experimental / Q000201:enzymology; D007945:Leukemia, Lymphoid / Q000201:enzymology*; D008223:Lymphoma / Q000201:enzymology*; D051379:Mice; D011119:Polynucleotides / Q000494:pharmacology*; D012328:RNA Viruses / Q000187:drug effects*
D000970:Antineoplastic Agents; D003854:Deoxyribonucleotides; D011119:Polynucleotides; D004254:DNA Nucleotidyltransferases; D012321:DNA-Directed RNA Polymerases; D003851:Deoxyribonucleases